STING1 and neoplasm: In the hypoxic milieu, the PTT/PDT attributes of the nanoprobe are also remarkably boosted, inducing strong tumor-specific T-cell immune responses and mitigating immunological resistance through the synergistic activation of both ICD and cGAS-STING pathways.